Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms.
from International: Top News And Analysis https://ift.tt/RYiQNZv
via IFTTT
Wednesday, March 8, 2023
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment